CLChang Liu

Chang Liu

*This is an algorithmically generated author record based on publicly available information.

Chang Liu has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sialic Acid Mediated Endothelial and Hepatic Uptake: A Mechanism based Mathematic Model Elucidating the Complex Pharmacokinetics and Pharmacodynamics of Efmarodocokin Alfa, a Variably Glycosylated Fusion Protein

    by Xun Tao, Siddharth Sukumaran, Gizette Sperinde, Chang Liu, Michelle Irwin Beardsley, Peter Day, Matt Kalo, Ebehiremen Ayewoh, Hao Cai, Yehong Wang, et al.


  • Open Access

    Utilizing PK and PD Biomarkers to Guide the First-in-Human Starting Dose Selection of MTBT1466A: A Novel Humanized Monoclonal Anti-TGFβ3 Antibody for the Treatment of Fibrotic Diseases

    by Rajbharan Yadav, Siddharth Sukumaran, Jeff Lutman, Mayur S. Mitra, Wendy Halpern, Tianhe Sun, A. Francesca Setiadi, Margaret Neighbors, X. Rebecca Sheng, Victor Yip, et al.


  • A Cell-Based FcRn-dependent Recycling assay for Predictive Pharmacokinetic assessment of Therapeutic Antibodies

    by Chang Liu, Yeon Su Kim, John Hok-Nin Lowe, Shan Chung

    Aim: Evaluation of suitable pharmacokinetic properties is critical for successful development of IgG-based biotherapeutics. The prolonged half-lives of IgGs depend on the intracellular trafficking ...


  • Open Access

    The GluN2B subunit represents a major functional determinant of NMDA receptors in human induced pluripotent stem cell-derived cortical neurons

    by Ioana Neagoe, Chang Liu, Alexander Stumpf, Yanmei Lu, Dongping He, Ross Francis, Jun Chen, Paul Reynen, Moulay Hicham Alaoui-Ismaili, Hirokazu Fukui


  • Open Access

    Mechanism-specific assay design facilitates the discovery of Nav1.7-selective inhibitors

    by Tania Chernov-Rogan, Tianbo Li, Gang Lu, Henry Verschoof, Kuldip Khakh, Steven W. Jones, Maureen H. Beresini, Chang Liu, Daniel F. Ortwine, Steven J. McKerrall, et al.

    Significance: Subtype-selective modulation of ion channels is often important, but extremely difficult to achieve for drug development. Using Nav1.7 as an example, we show that this challenge could be attributed to poor design in ion channel assays, which fail to detect most potent and selective compounds and are biased toward nonselective mechanisms. By exploiting different drug binding sites and modes of channel gating, we successfully direct a membrane potential assay toward non–pore-blocking mechanisms and identify Nav1.7-selective compounds. Our mechanistic approach to assay design addresses a significant hurdle in Nav1.7 drug discovery and is applicable to many other ion channels.


  • Open Access

    Erratum: Corrigendum: Lhx6-positive GABA-releasing neurons of the zona incerta promote sleep

    by Kai Liu, Juhyun Kim, Dong Won Kim, Yi Stephanie Zhang, Hechen Bao, Myrto Denaxa, Szu-Aun Lim, Eileen Kim, Chang Liu, Ian R. Wickersham, et al.

    Corrigendum: Lhx6-positive GABA-releasing neurons of the zona incerta promote sleep


  • Top Cited Papers

    Lhx6-positive GABA-releasing neurons of the zona incerta promote sleep

    by Kai Liu, Juhyun Kim, Dong Won Kim, Yi Stephanie Zhang, Hechen Bao, Myrto Denaxa, Szu-Aun Lim, Eileen Kim, Chang Liu, Ian R. Wickersham, et al.

    GABAergic Lhx6+ neurons in the ventral zona incerta promote both rapid eye movement and non-rapid eye movement sleep and inhibit the activity of wake-promoting GABAergic and Hcrt+ neurons of the lateral hypothalamus. Various populations of neurons that can promote wakefulness have been identified, but only a small number of neuronal populations that promote sleep have been described. Here, Seth Blackshaw and colleagues reveal that specific inhibitory neurons in the zona incerta become more active as sleep need increases, inhibiting the activity of wake-promoting neurons in the lateral hypothalamus. Midbrain deletion of Lhx6, a transcription factor that defines these inhibitory zona incerta neurons, can lead to decreases in both NREM and REM sleep. Further exploration of the gene expression networks that drive the development and function of these Lhx6-expressing neurons may identify other factors that are critical to sleep regulation. Multiple populations of wake-promoting neurons have been characterized in mammals, but few sleep-promoting neurons have been identified1. Wake-promoting cell types include hypocretin and GABA (γ-aminobutyric-acid)-releasing neurons of the lateral hypothalamus, which promote the transition to wakefulness from non-rapid eye movement (NREM) and rapid eye movement (REM) sleep2,3. Here we show that a subset of GABAergic neurons in the mouse ventral zona incerta, which express the LIM homeodomain factor Lhx6 and are activated by sleep pressure, both directly inhibit wake-active hypocretin and GABAergic cells in the lateral hypothalamus and receive inputs from multiple sleep–wake-regulating neurons. Conditional deletion of Lhx6 from the developing diencephalon leads to decreases in both NREM and REM sleep. Furthermore, selective activation and inhibition of Lhx6-positive neurons in the ventral zona incerta bidirectionally regulate sleep time in adult mice, in part through hypocretin-dependent mechanisms. These studies identify a GABAergic subpopulation of neurons in the ventral zona incerta that promote sleep.


  • Open Access

    GluA2-Containing AMPA Receptors Distinguish Ribbon-Associated from Ribbonless Afferent Contacts on Rat Cochlear Hair Cells

    by Rodrigo Martinez-Monedero, Chang Liu, Catherine Weisz, Pankhuri Vyas, Paul Albert Fuchs, Elisabeth Glowatzki

    Mechanosensory hair cells release glutamate at ribbon synapses to excite postsynaptic afferent neurons, via AMPA-type ionotropic glutamate receptors (GluAs). However, type II afferent neurons contacting outer hair cells in the mammalian cochlea were thought to differ in this respect, failing to show GluA immunolabeling and with many ‘ribbonless’ afferent contacts. Here it is shown that antibodies to the AMPA subunit GluA2 labeled afferent contacts below inner and outer hair cells in the rat cochlea, and that synaptic currents in type II afferents had AMPAR-specific pharmacology. Only half the postsynaptic densities of type II afferents that labelled for PSD95, Shank or Homer were associated with GluA2 immunopuncta or presynaptic ribbons, the ‘empty slots’ corresponding to ‘ribbonless’ contacts described previously. These results extend the universality of AMPA-ergic transmission by hair cells, and support the existence of silent afferent contacts. Significance Statement: Transmission from cochlear hair cells to afferent neurons is mediated by ionotropic glutamate receptors. Inner hair cells efficiently drive acoustic coding in type I afferents that express GluA2-containing AMPA receptors. Type II cochlear afferents differ from type I afferents not only in number, caliber, myelination and excitability, but also in the utility of their terminal contacts with hair cells. Outer hair cell to type II afferent transmission is far less effective, but also employs GluA2-containing receptors. Only half the type II afferent boutons that immuno-labeled for postsynaptic density proteins had GluA2 receptors. And, only GluA2-containing contacts were associated with presynaptic ribbons, the hair cell’s transmitter release active zones.


  • Unmyelinated type II afferent neurons report cochlear damage

    by Chang Liu, Elisabeth Glowatzki, Paul Albert Fuchs

    Significance: Painfully loud sound causes protective or withdrawal responses, rather than continued listening. This differential behavior invites comparison with somatic pain responses driven by the anatomically distinct subset of small-diameter, unmyelinated afferents—C fibers. Like somatic C fibers, unmyelinated type II cochlear afferents differ in size, number, and innervation pattern from type I afferents that encode sound. Here, we show that type II afferents are excited during cochlear tissue damage in part by the algogenic cytoplasmic metabolite adenosine triphosphate (ATP). This finding, together with previous evidence that type II afferents respond weakly to synaptic transmission from cochlear hair cells, and normally are insensitive to sound, supports the identification of type II afferents as cochlear nociceptors, mediating the sensation of painfully loud sound.


  • Postnatal Refinement of Auditory Hair Cell Planar Polarity Deficits Occurs in the Absence of Vangl2

    by Catherine O. Copley, Jeremy S. Duncan, Chang Liu, Haixia Cheng, Michael R. Deans

    The distinctive planar polarity of auditory hair cells is evident in the polarized organization of the stereociliary bundle. Mutations in the core planar cell polarity gene Van Gogh-like 2 (Vangl2) result in hair cells that fail to properly orient their stereociliary bundles along the mediolateral axis of the cochlea. The severity of this phenotype is graded along the length of the cochlea, similar to the hair cell differentiation gradient, suggesting that an active refinement process corrects planar polarity phenotypes in Vangl2 knock-out (KO) mice. Because Vangl2 gene deletions are lethal, Vangl2 conditional knock-outs (CKOs) were generated to test this hypothesis. When crossed with Pax2–Cre, Vangl2 is deleted from the inner ear, yielding planar polarity phenotypes similar to Vangl2 KOs at late embryonic stages except that Vangl2 CKO mice are viable and do not have craniorachischisis like Vangl2 KOs. Quantification of planar polarity deficits through postnatal development demonstrates the activity of a Vangl2-independent refinement process that rescues the planar polarity phenotype within 10 d of birth. In contrast, the Pax2–Cre;Vangl2 CKO has profound changes in the shape and distribution of outer pillar cell and Deiters9 cell phalangeal processes that are not corrected during the period of planar polarity refinement. Auditory brainstem response analyses of adult mice show a 10–15 dB shift in auditory threshold, and distortion product otoacoustic emission measurements indicate that this mild hearing deficit is of cochlear origin. Together, these data demonstrate a Vangl2-independent refinement mechanism that actively reorients auditory stereociliary bundles and reveals an unexpected role of Vangl2 during supporting cell morphogenesis.